FDA begins process that could authorize Pfizer vaccine for 5-11 year olds

On Tuesday, a Food and Drug Administration advisory panel debates whether to recommend the Pfizer COVID-19 vaccine to kids between ages 5 to 11. Full authorization could come by the end of the week.

We get the latest from NPR's Allison Aubrey.